FDA Requests Public Comment on Statement of Work for Communication with Sponsors During Prescription Drug Application Review

Summary

The Food and Drug Administration (FDA) is seeking public input on a statement of work aimed at improving communication between FDA and pharmaceutical sponsors through product quality information requests during the application review process, as part of the Prescription Drug User Fee Act (PDUFA) reauthorization.